RT @cbtadvisors: Newly public $KNTE Kinnate Biopharma opens at over $40 after pricing at an increased initial price of $20. Targets kinase…
RT @cbtadvisors: Newly public $KNTE Kinnate Biopharma opens at over $40 after pricing at an increased initial price of $20. Targets kinase…
© Nextech Invest Ltd. | privacy policy